What obesity drugmakers see next in the market: More pills, easier access and drug combinationsCNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.{}

CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.https://www.cnbc.com/2026/01/23/weight-loss-glp-1-drugs-next-steps-for-eli-lilly-novo-nordisk-pfizer.html